IN-DATE
FP-23-AD008: Bard GuardIVa Antimicrobial Hemostatic IV Dressing w/CHG, 4.0mm Hole
Sign in to add this product to your favorites!
| Price: | $699.00 per case of 100 |
|---|---|
| Quantity: | |
| In Stock: | 1 case of 100 |
| Expiration: | 02-2026 |
| Express: | Need it tomorrow? Order in next 5 hours 18 minutes and choose overnight shipping at checkout for Monday delivery. If you require Saturday delivery, please call to determine if it is available in your area - 888-416-2409. |
Related Items
QUICK VIEW
| AEG014S $49.00 per box of 10 Medline AEGIS CHG Impregnated Foam Disc 2.5cm, 4mm Hole Exp: 06-2027 Units in stock: 3 box of 10 | Order Qty |
QUICK VIEW
| FP-22-AD004 $699.00 per case of 100 Bard GuardIVa Antimicrobial Hemostatic IV Dressing w/CHG, 1.5mm Hole Exp: 03-2026 Units in stock: 2 case of 100 | Order Qty |
|
QUICK VIEW
| FP-24-AD012 $699.00 per case of 100 Bard GuardIVa Antimicrobial Hemostatic IV Dressing w/CHG, 7.0mm Hole Exp: 04-2026 Units in stock: 2 case of 100 | Order Qty |
QUICK VIEW
| ABS-4006 $29.00 EACH Arthrex JumpStart 1.5" x 10" Antimicrobial Wound Dressing Exp: 11-2025 (or later) Units in stock: 12 | Order Qty |
Additional Details
GuardIVa Antimicrobial Hemostatic IV Dressing
GuardIVa® Antimicrobial Hemostatic IV Dressing is an IV site care solution that combines the antimicrobial protection of chlorhexidine gluconate (CHG), a well-known antiseptic agent with broad spectrum antimicrobial and antifungal activity, with the proprietary hemostatic agent which controls surface bleeding from percutaneous catheters and vascular access sites.
Manufacturer
C.R. Bard (a part of BD - Becton, Dickinson and Company) was a global leader in the development and manufacturing of innovative medical technologies. Known for their high-quality products, Bard specialized in solutions for vascular access, urology, oncology, and surgical specialties. Their product portfolio included catheters, biopsy devices, implantable ports, and hernia repair systems, designed to enhance patient care and procedural efficiency. As part of BD, the legacy of C.R. Bard continues to drive advancements in healthcare, delivering trusted solutions that improve outcomes for patients and providers worldwide.
